Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Patient and Visit Characteristics on Health Outcomes in Knee Osteoarthritis
NCT06574191Recruiting
- Sponsor
- University of California, Davis
- Start
- Jan 2025
- Primary completion
- Jan 2028
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of diclofenac in knee osteoarthritis (OA), sponsored by University of California, Davis. Primary endpoints: Knee Pain at 8 weeks and Knee Function at 8 weeks. Started Jan 2025; status: recruiting.
02
Drugs
diclofenac
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06574191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06574191.